rimantadine has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chizhmakov, IV | 1 |
| Geraghty, FM | 1 |
| Ogden, DC | 1 |
| Hayhurst, A | 1 |
| Antoniou, M | 1 |
| Hay, AJ | 1 |
1 other study available for rimantadine and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells.
Topics: Animals; Cell Membrane Permeability; Electric Conductivity; Hydrogen-Ion Concentration; Influenza A | 1996 |